Zuglimin 500mg Strip Of 10 Tablets
10 Tablet(s) in StripMRP ₹75.00
₹62.25
17% OFF
Made by
ZUVENTUS HEALTH CARE LTD
Dosage
TABLET
Expiry
Product Summary
| Salt Content | Imeglimin Hydrochloride(500.0 Mg) |
| Uses | Type 2 diabetes |
| Therapy | Anti-diabetic |
| Side effects | Nausea, Diarrhea and Constipation. |
Assurance
available
Regulated
Medical Description
Zuglimin tablet is a medication used to treat type 2 diabetes. It aids the pancreas in producing more insulin, enhances pancreatic function, and safeguards human cells from deterioration. It boosts insulin secretion and sensitivity while reducing peripheral insulin resistance.
Side effects of Zuglimin tablet include nausea, diarrhea, constipation, weakness, feeling hungry and sweating. Zuglimin tablet is to be taken orally. Swallow the tablet with plenty of water; do not chew or crush it.
Uses
Contraindications
- If you are allergic to Zuglimin tablet or any of its components.
- If you have high levels of ketones in your body (ketosis), are in a serious health crisis like a diabetic coma or near it, are about to have surgery, or are hurt.
- If you have type 1 diabetes or infections
- If you are pregnant or breastfeeding.
- If you are taking any other medicinal products (some medicines may interact, either enhancing or diminishing their effects, so be cautious with over-the-counter medicines, dietary supplements, and other prescription medications).
Side effects
- Nausea
- Diarrhea
- Constipation
- Weakness
- Feeling hungry
- Sweating
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You have any allergic reactions after taking Zuglimin tablet.
- You have any pre-existing medical conditions such as heart disorder, liver or kidney problem, thyroid, etc.
- You are getting suicidal thoughts after taking Zuglimin tablet.
- You are experiencing vision problems or dizziness and sleepiness.
Directions for Use
- Zuglimin tablet is to be taken orally.
- Swallow the tablet with plenty of water; do not chew or crush it.
- Strictly adhere to the instructions regarding dietary and exercise therapy.
- If you experience hypoglycemic symptoms (hunger, cold sweat, pale complexion, easy fatigue, limb tremors, convulsions, decreased consciousness, etc.), consume foods containing sugar or sugar itself.
- Follow your doctor's advice and undergo regular blood tests.
Storage and disposal
- Store Zuglimin tablet at temperatures below 30°C.
- Protect Zuglimin tablet from light and moisture.
- Keep it out of children's reach.
Dosage
Overdose
Missed a Dose
Mode of Action
How Does It Work?
Interactions
Interactions with other medicines
- Some medicines can affect the way Zuglimin tablet functions, or Zuglimin tablet itself can diminish the effectiveness of other medicines taken concurrently.
- Inform your doctor about all the medicines, supplements, or herbal products you are currently taking or may take to avoid any potential interactions.
- If you are taking medicines that lower blood sugar levels, this could lead to additive effects with Zuglimin tablet. Always keep something sweet on hand to manage such situations, and monitor your blood sugar levels regularly.
Frequently Asked Questions (FAQs)
Articles
View All
Chronic Condition Articles
View All
Did you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:ZUGLIMIN
Manufacturer Name:ZUVENTUS HEALTH CARE LTD
Address:Exemed pharmaceuticals - Plot no 133/1 & 133/2,selvas road,vapi 396195,district valsad,gujarat.
Country of Origin:India
Vendor Details
Fulfillment Information: Zuglimin 500 MG Tablet (10) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
References:
- PubChem. Imeglimin Hydrochloride [Internet]. Nih.gov. PubChem; 2025 [cited 04 Mar 2025].
- Diabetology – Centaur Pharmaceuticals Pvt Ltd [Internet]. Centaurpharma.com. 2020 [cited 4 Mar 2025].
- Clémence C, Fouqueray P, Sébastien B. In Vitro Investigation, Pharmacokinetics, and Disposition of Imeglimin, a Novel Oral Antidiabetic Drug, in Preclinical Species and Humans. Drug Metabolism and Disposition. 2020 Oct 5;48(12):1330–46. [cited 04 Mar 2025].
- Singh AK, Singh A, Singh R, Misra A. Efficacy and safety of imeglimin in type 2 diabetes: A systematic review and meta-analysis of randomized placebo-controlled trials. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2023 Feb;17(2):102710. [cited 04 Mar 2025].
- Hydrochloride I. Report on the Deliberation Results [Internet]. 2021 [cited 04 Mar 2025].
- Giruzzi M. Imeglimin. Clinical Diabetes. 2021 Aug 12;39(4):439–40. [cited 04 Mar 2025].
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.
